Transcranial Magnetic Stimulation for Chronic Pain

This trial explores the use of transcranial magnetic stimulation (TMS), a non-invasive treatment, to determine its effectiveness in reducing chronic pain. Researchers aim to assess whether this treatment is practical, well-tolerated by patients, and effective in lowering pain levels. Suitable candidates have experienced chronic neuropathic pain for at least three months and maintain a stable pain medication routine. Participants will undergo different sequences of TMS treatment to compare its effects. As a Phase 1 trial, the research focuses on understanding how the treatment works in people, offering participants the opportunity to be among the first to receive this innovative therapy.

Earlier studies have shown that transcranial magnetic stimulation (TMS) holds promise for chronic pain relief. Research indicates that patients generally tolerate TMS well. For instance, one study with 193 patients found that 42% experienced significant pain relief. Importantly, no serious side effects emerged, making TMS a viable option for many.

Additionally, the FDA has already approved TMS for treating conditions like depression and migraines, suggesting its safety. The most common side effects are mild, including headaches, discomfort at the treatment site, and tiredness. These effects are usually temporary and manageable.

Researchers are excited about Transcranial Magnetic Stimulation (TMS) for chronic pain because it offers a non-invasive alternative to traditional pain management methods like opioids, which can have significant side effects and addiction risks. Unlike medications that work chemically, TMS uses magnetic fields to stimulate nerve cells in the brain, potentially altering pain perception. This treatment is unique in its ability to target specific areas of the brain, offering a personalized approach to pain relief. Additionally, TMS can provide benefits without the systemic side effects often associated with pharmacological treatments, making it a promising option for those seeking alternative pain management solutions.

This trial will evaluate the effectiveness of transcranial magnetic stimulation (TMS) for chronic pain. Research has shown that TMS might reduce long-term pain by affecting brain areas involved in pain processing, potentially lowering pain levels. Participants will experience different sequences of TMS, including real on-target and off-target control sessions, to assess its impact on pain management. Although researchers continue to study TMS for long-term pain, these initial findings are promising for its ability to manage pain.⁶⁷⁸⁹¹⁰